淋巴结Langerhans细胞组织细胞增生症1例并文献复习
Langerhans Cell Histiocytosis in Lymph Nodes: A Case Report and Review of the Literature
DOI: 10.12677/ACM.2016.64026, PDF, HTML, XML, 下载: 1,970  浏览: 2,725 
作者: 廖谦和, 徐 丹:沭阳人民医院病理科,江苏 沭阳
关键词: 淋巴结Langerhans细胞组织细胞增生症诊断临床病理学Lymph Node Langerhans Cell Histiocytosis Diagnosis Clinicopathology
摘要: Langerhans细胞组织细胞增生症(Langerhans cell histiocytosis, LCH)是一种主要由Langerhans细胞克隆性肿瘤性增生形成的肿瘤性疾病,单系统发生在淋巴结者少见,临床上经常发生误诊。本例患者男性,45岁,以发热伴右腹股沟肿块1个月余入院。光镜下淋巴结基本结构几乎完全被破坏,病变主要由Langerhans细胞和嗜酸性细胞或嗜酸性脓肿组成。Langerhans细胞中等至偏大,胞质丰富嗜酸性,细胞核圆形、卵圆形,咖啡豆样核或不规则,有明显的核沟纹。病灶中有散在的多核巨细胞和数量不等的嗜酸性粒细胞浸润,可见嗜酸性脓肿。免疫组化标记显示瘤细胞表达S-100、CD1a、CD68、vimentin,而不表达HMB45,CD21、CD45、CD20、CD3、CK、CD30、EMA。患者术后恢复良好。
Abstract: Langerhans cell histiocytosis (LCH) is a neoplastic diseases majorly formed by the clonal neoplastic proliferation of Langerhans cells, and single-system which occurs in the lymph nodes is rare. So the clinical misdiagnosis often occurs. In this case, a 45-year-old man was admitted to hospital with a history of fever and a right groin mass for more than one month. Under microscopy, the structure of the lymph node was almost damaged, which was caused by the idiopathic proliferation of Langerhans cell and eosinophils or eosinophilic abscess. The Langerhans cells ranged from medium to relatively large in size and the cytoplasm is rich and eosinophilic. The nuclear was round, oval, bean-like or irregular in shape, showing clear grooves and depressions. Immunohistochemical study showed that the Langerhans cells were strongly positive for S-100 protein, CD1a, CD68, vimentin, and negative for HMB45, CD21, CD45, CD20, CD3, CK, CD30, EMA. The patient was recovered well after surgery.
文章引用:廖谦和, 徐丹. 淋巴结Langerhans细胞组织细胞增生症1例并文献复习[J]. 临床医学进展, 2016, 6(4): 147-150. http://dx.doi.org/10.12677/ACM.2016.64026

参考文献

[1] Lo, W.C., Chen, C.C., Tsai, C.C., et al. (2009) Isolated Adult Langerhans’ Cell Histiocytosis in Cervical Lymph Node: Should It Be Treated? The Journal of Laryngology & Otology, 123, 1055-1057.
http://dx.doi.org/10.1017/S0022215108004155
[2] Swerdlow, S.H., Campo, E., Harris, N.L., et al. (2008) World Health Or-ganization Classification of Tumours. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 280-283.
[3] Badalian-Very, G., Vergilio, J.A., Degar, B.A., et al. (2010) Recurrent BRAF Mutations in Langerhans Cell Histio-cytosis. Blood, 116, 1919-1923.
http://dx.doi.org/10.1182/blood-2010-04-279083
[4] Bubolz, Z.M., Weissinger, S.E., Stenziger, A., et al. (2014) Potential Clinical Implications of BRAF Mutations in Histiocytic Proliferations. Oncotarget, 5, 4060-4070.
http://dx.doi.org/10.18632/oncotarget.2061
[5] Tong, C., Jia, X., Jia, Y., et al. (2014) Langerhans Cell Histiocytosis in Chinese Adults: Absence of BRAF Mutations and Increased FOXP3(+) Regulatory T Cells. International Journal of Clinical and Experimental Pathology, 7, 3166- 3173.
[6] Zhong, W.Q., Jiang, L., Ma, Q.J., et al. (2010) Langerhans Cell Histiocytosis of the Atlas in an Adult. European Spine Journal, 19, 19-22.
http://dx.doi.org/10.1007/s00586-009-1172-9
[7] Wang, Y.N., Zhou, X.G., Wang, Z., et al. (2012) Langerhans Cell Sarcoma of Cervical Lymph Node: A Case Report and Literature Review. Acta Haematologica, 129, 114-120.
http://dx.doi.org/10.1159/000342103
[8] 泥永安, 孙立荣. 朗格汉斯细胞组织细胞增生症治疗进展[J]. 临床儿科杂志, 2015, 33(3): 291-294.
[9] 李旻, 刘艳辉, 庄恒国, 等. T-淋巴母细胞淋巴瘤合并朗格汉斯细胞组织细胞增生症临床病理观察[J]. 诊断病理学杂志, 2012, 19(3): 217-220.